| COVID-19: vaccine delivery system, drug repurposing and application of molecular modeling approach SR Abd El Hadi, EE Zien El-Deen, MM Bahaa, AA Sadakah, HA Yassin Drug design, development and therapy, 3313-3330, 2021 | 11 | 2021 |
| Open‐label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to irritable bowel syndrome SM El‑Haggar, SK Hegazy, S M. Abd‐Elsalam, MM Bahaa Journal of Clinical Pharmacy and Therapeutics 47 (3), 306-312, 2022 | 9 | 2022 |
| Nitazoxanide-based therapeutic regimen as a novel treatment for Helicobacter pylori infection in children and adolescents: a randomized trial D Shawky, AM Salamah, SM Abd-Elsalam, E Habba, MH Elnaggar, ... Eur Rev Med Pharmacol Sci 26 (9), 3132-3137, 2022 | 7 | 2022 |
| Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine SM El‑Haggar, SK Hegazy, SM Abd-Elsalam, MM Bahaa Biomedicine & Pharmacotherapy 145, 112399, 2022 | 5 | 2022 |
| A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new … SJ Alarfaj, MM Bahaa, HA Yassin, E El-Khateeb, FA Kotkata, ... European Review for Medical & Pharmacological Sciences 27 (16), 2023 | 4 | 2023 |
| Calprotectin in Parkinsonian disease: Anticipation and dedication HM Al-Kuraishy, AI Al-Gareeb, A Alexiou, M Papadakis, MM Bahaa, ... Ageing research reviews, 102143, 2023 | 3 | 2023 |
| Covid‐19 and risk of acute pancreatitis: What beyond HM Al‐kuraishy, AI Al‐Gareeb, A Alexiou, M Papadakis, MM Bahaa, ... Journal of Cellular and Molecular Medicine 28 (1), 2024 | 1 | 2024 |
| Cyclin‐dependent kinase 5 (CDK5) inhibitors in Parkinson disease M Alrouji, HM Al‐kuraishy, AI Al‐Gareeb, MS Alshammari, A Alexiou, ... Journal of Cellular and Molecular Medicine 28 (11), e18412, 2024 | | 2024 |
| Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized … KM Aldossary, LS Ali, MS Abdallah, MM Bahaa, TA Elmasry, EI Elberri, ... Frontiers in Pharmacology 15, 1381523, 2024 | | 2024 |
| The compelling role of allopurinol in hyperuricemia-induced epilepsy: Unrecognized like tears in rain AA AlAseeri, HM Al-Kuraishy, AI Al-Gareeb, NH Ali, A Alexiou, ... Brain Research Bulletin, 110973, 2024 | | 2024 |
